At Rhythm, we are passionate about transforming the lives of people living with rare genetic diseases of obesity.
At Rhythm, you’ll work alongside an extremely talented team—one that brings its best each day and works with vision and dedication.
We are committed to changing how rare genetic diseases of obesity are diagnosed and treated. The company has been on a deliberate growth trajectory since its founding in 2011 and through IPO in 2017.
Now, Rhythm is a commercial-stage, fully integrated biopharmaceutical company with several late-phase trials across multiple indications.